GeneDx Holdings Corp.
WGS· Nasdaq
WGSGeneDx Holdings Corp.
Filed Feb 20, 2025 · 10-K · 51 days after period end · 0001818331-25-000021
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Revenue | $95.64M | $57.42M | $61.35M | $57.80M |
| Net Income | $5.44M | -$25.77M | -$308.76M | -$40.19M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Feb 20, 2025 · 51 d after period end
